2024

Your Guide to Navigating Seattle for ARVO 2024

We’re excited to see everyone at ARVO 2024 in Seattle in May! Every year, we are impressed and humbled by the incredible presentations and posters that highlight breakthrough research related to new disease models, diagnostics, and therapies. Phoenix-Micron is headquartered in the Northwest, and many of our team members are either from the Seattle area

2023

Phoenix-Micron, Inc. launches the next generation of its MICRON in vivo ophthalmic imaging platform for small animal research

The all-new MICRON® 5 platform delivers advanced performance, repeatability, and imaging workflow efficiency Bend, OR, USA, April 21, 2023 – Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform

2023

Phoenix-Micron, Inc. Announces New, Comprehensive Imaging Software and Redesigned Lens Technology for the Phoenix MICRON® Imaging Platform

Two new innovations, MICRON Software Suite and MICRON LT2 lens technology, streamline the ophthalmic imaging workflow and deliver new data management capabilities.   Bend, OR, USA, April 21, 2023–  Phoenix-Micron, Inc., a leader in ophthalmic imaging technology, today announced the release of the new MICRON® Software Suite and the MICRON LT2 lens technology. The new

2022

Where do research ideas come from?

Where do research ideas come from?  Do they arrive in a thunderbolt eureka moment, or do they start as an observation or hunch, requiring some time to simmer, brew, incubate and grow?  Some may evolve from an accidental or serendipitous discovery during a routine process. Observant operators of the Phoenix MICRON® retinal imaging system may

2021

Subretinal injection damage has implication for experimental control and treatment in rat model of retinopathy of prematurity

In their 2017 article, “Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model,” Becker et al used the Phoenix MICRON® IV fundus camera, Phoenix MICRON® OCT2 and corresponding layer analysis software Insight 2D, and the Phoenix MICRON® focal ERG to find that subretinal injection of saline or even introduction

2021

Stunning fundus images of GFP-positive cells demonstrate new intravitreal injection technique

In their article, “A Novel Method Combining Vitreous Aspiration and Intravitreal AAV2/8 Injection Results in Retina-Wide Transduction in Adult Mice,” Da Costa et al use the Phoenix MICRON® III imaging platform to take stunning images demonstrating the success of their novel intravitreal injection technique. Gene therapy is a promising treatment option of genetic retinopathies—adeno-associated viruses

1 2 3 4